NASDAQ$PAYS

Paysign Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported third quarter 2020 financial results, noting the pandemic's continued impact on the business due to its adverse effect on clients in the pharma and plasma industries.

Paysign reported its third quarter 2020 financial results, acknowledging the ongoing impact of the pandemic on its business, particularly affecting clients in the pharma and plasma industries. The company remains optimistic about recovery and targets a return to year-over-year growth, contingent on the pandemic's effects. Paysign is well-capitalized and anticipates an upturn in the fourth quarter from new client programs.

  • The pandemic continues to significantly impact Paysign's business, particularly affecting clients in the pharma and plasma industries.
  • Paysign remains cautiously optimistic about the recovery of its clients and aims to return to year-over-year growth, depending on the pandemic's effects.
  • The company is well-capitalized and prepared to withstand ongoing pandemic-related impacts.
  • Paysign anticipates an additional upturn in the fourth quarter due to the onboarding of new client programs.

Headline financials

Total Revenue

-$153K

Previous: $9.01M-101.7%
EPS (adj)

-$0.14

Previous: $0.06-333.3%
Capital Expenditures

-$1.1M

Previous: -$351K-212.1%
Free Cash Flow

-$7.25M

Previous: $2.61M-377.9%
Net Income

-$6.15M

Previous: $2.96M-307.8%
Operating Income

-$8.42M

Previous: $2.28M-469.2%
Gross Profit

-$3.43M

Previous: $5.37M-164.0%
Cash & Equivalents

$55.5M

Previous: $41.2M+34.7%
Total Assets

$71.1M

Previous: $47.6M+49.3%
Stock-Based Comp

$799K

Previous: $651K+22.7%

Revenue & EPS history

Paysign · Revenue · Quarterly

-$153K

Q3 2020-101.7%vs Q3 2019
Beat estimate in 5 of 11 quarters(45%)
ActualEstimate

Forward guidance

Paysign anticipates an upturn in the fourth quarter resulting from new client programs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+16.2%

Avg return

Earnings day

+4.1%

Avg return

5 days after

+7.8%

Avg return

30 days after

44%

27 / 61 earnings

Positive

+900.0%

Q3 2011

Best reaction

-29.6%

Q4 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+37.3%-4.3%
Q1 2026-12.6%-12.0%+4.8%
Q3 2025+0.2%-8.8%+0.4%
Q2 2025+13.0%+4.2%+0.6%
Q1 2025+3.0%+22.9%+81.9%
Q4 2024-8.5%-14.5%-8.1%
Q3 2024+10.9%+8.7%-7.9%
Q2 2024-6.7%-14.4%-9.2%
Q1 2024-0.4%+5.4%-7.6%
Q4 2023+20.5%+10.2%+31.9%
Q3 2023+18.1%+21.6%+18.1%
Q2 2023+6.4%+8.6%+16.0%
Q1 2023-1.8%-4.5%-20.7%
Q4 2022+4.2%+7.6%+0.3%
Q3 2022-10.4%+8.9%+16.5%
Q2 2022+7.4%+15.3%+33.5%
Q1 2022-26.2%-20.2%-2.4%
Q4 2021-6.6%-16.6%-21.4%
Q3 2021-9.0%-14.6%-32.8%
Q2 2021-2.4%+5.6%+16.7%
Q1 2021-11.4%-10.8%+0.0%
Q4 2020+11.7%+5.1%+0.8%
Q3 2020-26.8%-20.6%-7.7%
Q2 2020-18.9%-30.5%-45.3%
Q1 2020-5.5%-13.0%-0.4%
Q4 2019+27.3%+82.9%+102.7%
Q3 2019+13.2%+17.1%+3.9%
Q2 2019+2.5%+6.3%+2.7%
Q1 2019-11.7%-6.7%+18.2%
Q4 2018-1.7%-7.5%-1.0%
Q3 2018-0.5%-1.6%-6.3%
Q2 2018+10.1%+2.7%-2.7%
Q1 2018-0.9%+18.8%+23.1%
Q4 2017+19.0%+20.6%+44.3%
Q3 2017+7.9%+19.3%+15.8%
Q2 2017+2.8%+9.4%+0.0%
Q1 2017-8.7%-6.5%-6.5%
Q4 2016+4.7%+0.0%+0.0%
Q3 2016+34.9%+73.7%+73.7%
Q2 2016+0.0%-5.0%-20.0%
Q1 2016-23.2%
Q4 2015-29.6%
Q3 2015-12.0%
Q2 2015+6.3%
Q1 2015+4.3%
Q4 2014+71.2%
Q2 2014-16.7%
Q1 2014+0.0%
Q4 2013+23.4%
Q3 2013-17.9%
Q2 2013-16.6%
Q4 2012-4.3%
Q1 2013-4.3%
Q3 2012+18.5%
Q2 2012+0.0%
Q1 2012+0.0%
Q4 2011+0.0%
Q3 2011+900.0%
Q2 2011+0.0%
Q1 2011+0.0%
Q4 2010+5.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro